Upload
baylee
View
34
Download
0
Embed Size (px)
DESCRIPTION
Supply of OPV for Pulse Polio Immunization Programme . Twenty Third Meeting Of the India Expert Advisory Group (IEAG) for Polio Eradication on 13-14 July 2011 Presentation by S N Panda General Manager, Rites Ltd. Structure of Presentation. Supply of OPV in 2010-11 - PowerPoint PPT Presentation
Citation preview
Supply of OPV for Pulse Polio Immunization
Programme
Twenty Third Meeting Of
the India Expert Advisory Group (IEAG) for Polio Eradication
on13-14 July 2011
Presentation by
S N Panda General Manager, Rites Ltd
Structure of Presentation
• Supply of OPV in 2010-11• Summary of Rites Experience in 2010-11• OPV Procurement Status for 2011-12 rounds• Recommendation of RITES
Introduction• M/s RITES Limited (A PSU under Ministry of Rlys)
assisting the Department of Health & Family Welfare as Procurement Agent for procurement of OPVs funded by External Agencies like World Bank since May’ 2010
• In FY 2010-11 five indents were processed for four types of vaccines like bOPV, tOPV,mOPV1 and mOPV3. Shortfall quantities were procured by MoHFW through domestic budget.
• In FY 2011-12 two indents are being processed for bOPV and tOPV.
Vaccine Supply Objectives
To ensure a sustained and uninterrupted supply of quality vaccines
Through
• WHO Prequalification• Appropriate contracting
Supply of OPV in 2010-11
OPV Indent Qty to RITES (Million Doses)
Qty procured by RITES (Million dosess)
Qty procured by MoHFW (Million dosess)
bOPV 162 99.6 139.11
tOPV 471 246.49 190
mOPV1 37.5 15 Rest Qty was not required
RITES Experience
Response From Suppliers in 2010-11 Tenders with Externally Aided Component
OPV Number of WHO prequalified Firms
Number of Participated Firms
Remarks
bOPV 4 2 Only Indian suppliers participated
tOPV 6 3 One foreign supplier participated
mOPV1 6 3 One foreign supplier participated
Installed Capacity of OPV Suppliers participated in Rites Tender
Firm Name Installed Capacity Million Doses per annum
M/s Panacea Biotec 1600M/s Haffkine 600M/s Sanofi Pasture 4000M/s Bharat Biotech 1382.40 *
* Received their WHO prequalification on 15.06.2011
Summary of Rites Experience in 2010-11
• 50% of qualified suppliers participated in Bid• Mostly suppliers from India participated
though it was a LIB except M/s Sanofi from France
• No offer for full Bid quantity• Appreciable gap in offered price of different
suppliers
Reasons for low response
• Demand- Supply gap• Shortage of bulk in International market• Non participation of foreign suppliers due to
(i) supply of OPV in short notice and (ii) shelf life of minimum 18 months on the
date of arrival at port of entry in India
Supply of OPV in 2011-12
OPV Qty procured by MoHFW (Million doses)- March to June’11
Indent Qty to RITES (Million Doses)-Sept’11 onwards
Remarks
bOPV 164.8 254.9 Bid Opened on 20/06/11, BER sent to WB on 08/07/11 for full Qty. WB NOL received on date.
tOPV 0 450 LIB floated by RITES, bid opening on 25.7.2011
Note: No shortfall in supply is perceived at this moment.
OPV Procurement Status for 2011-12 rounds
OPV Indent Qty (Million Doses)
Delivery Requirement
Remarks
bOPV 92.6 07/09/2011 Bid Opened on 20/06/11, BER sent to WB on 08/07/11 for full Qty. WB NOL received on date.
39.5 31/10/201192.6 28/02/201130.2 07/09/2011
Total 254.90tOPV 225 27/12/2011 Bid Opening on
25/07/2011. 225 23/01/2011Total 450
Recommendation of RITES
• Indent should be sent at least 12 months in advance with respect to supply requirement so that tender can be finalised six months prior to requirements. This implies advanced planning and long term IEAG recommendations.
Thank You